![Canadian Urological Association (CUA) artwork](https://is3-ssl.mzstatic.com/image/thumb/Podcasts115/v4/dc/c2/c2/dcc2c2a9-5e05-5d68-4ad5-ffa0d3633db4/mza_16854314293958814532.jpg/100x100bb.jpg)
CUA Highlights of ASCO 2021 - Bladder Cancer session
Canadian Urological Association (CUA)
English - June 09, 2021 04:00 - 59 minutes - 54.7 MBMedicine Health & Fitness Science Life Sciences medicine urologic urology Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: CUA Practice Changing Publications (PCP) in Pediatric Urology
Next Episode: Milestones in Advanced Bladder Cancer
Disclosures:
Fabio Cury
Educational grants: Sanofi S.A., Boston Scientific
Honoraria/Travel Support: Varian Medical Systems, Bayer AG, Abbvie
Neil Fleshner
Payment: Astellas, Janssen, Abbvie, Sanofi, Merck
Grant/Honorarium: Astellas, Janssen, Bayey
Investments: Verity Pharma
Clinical Trials: Astellas, Janssen, Bayer
Leadership position: Point Biopharma
Di (Maria) Jiang
Speaker's honoraria: Ipsen, Janssen, Bayer